Cargando…

Interleukin-27: a novel biomarker in predicting bacterial infection among the critically ill

INTRODUCTION: A continued need exists for effective diagnostic biomarkers in bacterial sepsis among critically ill patients, despite increasing use of available biomarkers such as procalcitonin (PCT). Interleukin-27 (IL-27) has shown early promise in a recent preliminary study, exhibiting high speci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hanna, William J., Berrens, Zachary, Langner, Travis, Lahni, Patrick, Wong, Hector R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627377/ https://www.ncbi.nlm.nih.gov/pubmed/26514771 http://dx.doi.org/10.1186/s13054-015-1095-2

Ejemplares similares

Interleukin-27 as a candidate diagnostic biomarker for bacterial infection in immunocompromised pediatric patients
por: Jacobs, Lauren, et al.
Publicado: (2018)

Interleukin-27 is a novel candidate diagnostic biomarker for bacterial infection in critically ill children
por: Wong, Hector R, et al.
Publicado: (2012)

The Pediatric Sepsis Biomarker Risk Model (PERSEVERE) Biomarkers Predict Clinical Deterioration and Mortality in Immunocompromised Children Evaluated for Infection
por: Jacobs, L., et al.
Publicado: (2019)

Biomarkers Estimating Baseline Mortality Risk for Neonatal Sepsis: nPERSEVERE: neonate-Specific Sepsis Biomarker Risk Model
por: Al Gharaibeh, Faris N., et al.
Publicado: (2023)

Interleukin-27 and Its Diverse Effects on Bacterial Infections
por: Morita, Yugo, et al.
Publicado: (2021)

Urine interleukin-18 and cystatin-C as biomarkers of acute kidney injury in critically ill neonates
por: Li, Yanhong, et al.
Publicado: (2012)

Identification of Interleukin-27 (IL-27)/IL-27 Receptor Subunit Alpha as a Critical Immune Axis for In Vivo HIV Control
por: Ruiz-Riol, M., et al.
Publicado: (2017)

Accuracy for Mortality Prediction With Additive Biomarkers Including Interleukin-6 in Critically Ill Patients: A Multicenter Prospective Observational Study
por: Yamamoto, Ryo, et al.
Publicado: (2021)

Interleukin-27 as a Diagnostic Biomarker for Patients with Sepsis: A Meta-Analysis
por: Wang, Ying, et al.
Publicado: (2021)

Interleukin-27 in T Cell Immunity
por: Iwasaki, Yukiko, et al.
Publicado: (2015)

Novel plasma protein biomarkers from critically ill sepsis patients
por: Van Nynatten, Logan R., et al.
Publicado: (2022)

Biomarkers of delirium in critically ill patients
por: Van den Boogaard, M, et al.
Publicado: (2011)

Ascitic Interleukin 6 Is Associated with Poor Outcome and Spontaneous Bacterial Peritonitis: A Validation in Critically Ill Patients with Decompensated Cirrhosis
por: Mayr, Ulrich, et al.
Publicado: (2020)

Biomarkers in critical illness: have we made progress?
por: Honore, Patrick M, et al.
Publicado: (2016)

Hsp72 Is a Novel Biomarker to Predict Acute Kidney Injury in Critically Ill Patients
por: Morales-Buenrostro, Luis E., et al.
Publicado: (2014)

Interleukin-6: obstacles to targeting a complex cytokine in critical illness
por: McElvaney, Oliver J, et al.
Publicado: (2021)

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
Publicado: (2021)

The Combined Use of Interleukin-6 with Serum Albumin for Mortality Prediction in Critically Ill Elderly Patients: The Interleukin-6-to-albumin Ratio
por: Lim, Kai Yang, et al.
Publicado: (2022)

Predictive biomarkers of mortality in critically ill patients with COVID-19()
por: Sirvent, J.M., et al.
Publicado: (2022)

Interleukin-27 as a Novel Biomarker for Early Cardiopulmonary Failure in Enterovirus 71-Infected Children with Central Nervous System Involvement
por: Huang, Mingyuan, et al.
Publicado: (2016)

64. Novel Biomarkers Improve Estimation of Vancomycin Clearance in Critically Ill Children
por: Downes, Kevin J, et al.
Publicado: (2021)

The Immunomodulatory Effects of Albumin In Vitro and In Vivo
por: Wheeler, Derek S., et al.
Publicado: (2011)

Inflammation biomarkers and delirium in critically ill patients
por: Ritter, Cristiane, et al.
Publicado: (2014)

Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis
por: Gorham, Julie, et al.
Publicado: (2020)

Biomarkers of Endothelial Activation Are Associated with Poor Outcome in Critical Illness
por: Mikacenic, Carmen, et al.
Publicado: (2015)

Glucocorticoid Receptor Expression in Peripheral WBCs of Critically Ill Children*
por: Shibata, Audrey R. Ogawa, et al.
Publicado: (2015)

The antitumor potential of Interleukin-27 in prostate cancer
por: Di Carlo, Emma, et al.
Publicado: (2013)

Interleukin-27 levels in patients with myasthenia gravis
por: Liu, Xiao-Jiao, et al.
Publicado: (2020)

High Mobility Group Box 1 and Interleukin 6 at Intensive Care Unit Admission as Biomarkers in Critically Ill COVID-19 Patients
por: Sivakorn, Chaisith, et al.
Publicado: (2021)

Oliguria as predictive biomarker of acute kidney injury in critically ill patients
por: Prowle, John R, et al.
Publicado: (2011)

Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients
por: Dujardin, Romein W.G., et al.
Publicado: (2020)

Interleukin-27: a potential new sepsis biomarker exposed through genome-wide transcriptional profiling
por: Scicluna, Brendon P, et al.
Publicado: (2012)

Olfactomedin 4 marks a subset of neutrophils in mice
por: Alder, Matthew N, et al.
Publicado: (2018)

Plasma Endogenous Sulfur Dioxide: A Novel Biomarker to Predict Acute Kidney Injury in Critically Ill Patients
por: Jiang, Yijia, et al.
Publicado: (2021)

Novel Percutaneous Tracheostomy for Critically Ill Patients With COVID-19
por: Angel, Luis, et al.
Publicado: (2020)

Bacterial and fungal superinfections in critically ill patients with COVID-19
por: Bassetti, Matteo, et al.
Publicado: (2020)

Probiotic Bacterial Application in Pediatric Critical Illness as Coadjuvants of Therapy
por: Zanza, Christian, et al.
Publicado: (2021)

Evaluating the Role of the Interleukin-23/17 Axis in Critically Ill COVID-19 Patients
por: Jahaj, Edison, et al.
Publicado: (2021)

The Role of Adipokines as Circulating Biomarkers in Critical Illness and Sepsis
por: Loosen, Sven H., et al.
Publicado: (2019)

Apelin-13 as a Potential Biomarker in Critical Illness
por: Gergics, Marin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_59qq6mfeu5tr03ut5lgfbd1fbo